PDL Practice Alert
PDL advice on reporting culture
The safety of a pharmacist’s patients should always be front of mind. Beyond a pharmacist’s clinical expertise, the culture within our healthcare settings significantly impacts patient outcomes One crucial aspect …
PDL appoints two new professional officers
PDL has announced the appointment of Kylie Neville and Dr Simone Henriksen as professional officers, joining Gary West, Jess Hadley and Naomi Lim Neville and Henriksen will work closely with …
UTI service to start in SA
For South Australian pharmacists about to start participating, there are lessons to be learned from UTI services around the country, writes PDL Beginning on 1 March 2024, South Australian pharmacists …
Tasmanian UTI pilot set to start
With the Tasmanian pilot to go live on 1 March, PDL has some advice Tasmanian pharmacists may be aware of the Tasmanian Community Pharmacy Program, scheduled to go live on …
Mitigating risks of the Opioid Therapy Program
PDL has some advice on common incidents involving the Opioid Therapy Program, following last year’s changes Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program …
Administering medicines by injection
PDL offers some timely advice on some of the risks and areas to focus on when administering medicines by injection In recent years, the pharmacy profession has seen significant expansion …
The top 10: PDL practice alerts
Next in our review of 2023, the year’s ten most viewed alerts and advice for pharmacists from PDL Mounjaro update Practising ‘good’ dispensing Focusing on patient privacy Be alert but …
Another variant vaccine, another potential risk
With the availability of the latest Pfizer (Comirnaty) Omicron XBB.1.5 vaccine, indicated for 12 years and over, there may be potential for selection or administration error, writes PDL This is …
Maintaining professional boundaries: A reminder for pharmacists
Meridian Lawyers has collaborated with PDL to prepare an article about professional boundaries and the types of conduct that are likely to be the subject of complaint to regulators. …
Pharmacy Board of Australia registration renewal
Every year, PDL receives calls from pharmacists who have overlooked their Pharmacy Board of Australia (PBA) registration renewal. This may happen due to renewal reminders being quarantined in junk …
Medicinal cannabis
The prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia With this emerging field comes the need for comprehensive risk management considerations and strategies …
Off-label prescribing: obligations, responsibilities and risk mitigation
PDL has some advice on off-label prescribing and their role in promoting the appropriate and safe use of these medicines Off-label prescribing occurs when a medication is used for a …